Read More Exclusives Interview Media EXCLUSIVE: First Wave BioPharma President & CEO, James Sapirstein, Now Interviewing On Benzinga’s ‘Benzinga Live’ YouTube Show, Discussing Co.’s COVID Trial By Benzinga Newsdesk Today, 2:04 AM https://www.youtube.com/watch?v=MjaMezfkWfM FWBI
Read More Analyst Ratings News Price Target Chardan Capital Maintains Buy on Senti Biosciences, Lowers Price Target to $8 By Benzinga Newsdesk Today, 2:04 AM Chardan Capital analyst Geulah Livshits maintains Senti Biosciences (NASDAQ:SNTI) with a Buy and lowers the price target from $12 to $8. SNTI
Read More Biotech FDA General Health Care News FDA Approves Second Indication For Merck’s Keytruda In Endometrial Cancer By Vandana Singh Today, 2:04 AM The ESALF
Read More News European Medicines Agency Increases Manufacturing Capacity For Pfizer COVID-19 Vaccine By Michael Horton Today, 2:04 AM -Reuters BNTX